JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GPX
4701
DELISTED
GP Strategies Corp.
GPX
| $27K | ﹤0.01% |
4,118
-98
| -2% | -$1.14K |
2017 Q4
9 quarters
|
|
|
AIG.WS
4702
DELISTED
American International Group, Inc.
AIG.WS
| – | – |
0
| – | – |
2015 Q4
17 quarters
|
|
|
CORV
4703
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $27K | ﹤0.01% |
69,947
-66,422
| -49% | -$24K |
2015 Q4
17 quarters
|
|
4704
iShares Morningstar Small-Cap Value ETF
ISCV
$657M
| $26K | ﹤0.01% |
900
-318
| -26% | -$13.2K |
2015 Q2
19 quarters
|
|
4705
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.45B
| $26K | ﹤0.01% |
+518
| New | +$25.9K |
2020 Q1
0 quarters
|
|
4706
Fidelity Nasdaq Composite Index ETF
ONEQ
$11.1B
| $26K | ﹤0.01% |
860
+60
| +8% | +$2.05K |
2019 Q1
4 quarters
|
|
4707
Pulse Biosciences
PLSE
$3.42B
| $26K | ﹤0.01% |
3,616
-71
| -2% | -$737 |
2017 Q4
9 quarters
|
|
4708
Senseonics Holdings Inc
SENS
$522M
| $26K | ﹤0.01% |
2,035
+28
| +1% | +$563 |
2017 Q4
9 quarters
|
|
|
IVAC
4709
DELISTED
Intevac Inc
IVAC
| $26K | ﹤0.01% |
6,455
-21,023
| -77% | -$126K |
2017 Q4
9 quarters
|
|
|
CHRA
4710
DELISTED
Charah Solutions, Inc Common Stock
CHRA
| $26K | ﹤0.01% |
1,541
+341
| +28% | +$7.93K |
2018 Q3
6 quarters
|
|
4711
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.35B
| $25K | ﹤0.01% |
+420
| New | +$29.6K |
2020 Q1
0 quarters
|
|
|
VTLE
4712
DELISTED
Vital Energy
VTLE
| $25K | ﹤0.01% |
3,316
-38,199
| -92% | -$1.11M |
2013 Q2
27 quarters
|
|
|
MFGP
4713
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $25K | ﹤0.01% |
5,016
-1,765
| -26% | -$17.9K |
2017 Q3
10 quarters
|
|
4714
Concrete Pumping Holdings
BBCP
$496M
| $24K | ﹤0.01% |
8,550
+3,278
| +62% | +$15.8K |
2019 Q1
4 quarters
|
|
|
GENZ
4715
VanEck Digital Native Economy ETF
GENZ
$16.4M
| $24K | ﹤0.01% |
+935
| New | +$34.3K |
2020 Q1
0 quarters
|
|
|
CAF
4716
Morgan Stanley China A Share Fund
CAF
$236M
| $24K | ﹤0.01% |
1,339
-1,202
| -47% | -$24K |
2018 Q4
5 quarters
|
|
4717
Evolus
EOLS
$472M
| $24K | ﹤0.01% |
5,951
-102
| -2% | -$864 |
2018 Q1
8 quarters
|
|
|
FARM
4718
DELISTED
Farmer Brothers
FARM
| $24K | ﹤0.01% |
3,410
-81
| -2% | -$941 |
2013 Q2
27 quarters
|
|
4719
Mustang Bio
MBIO
$3.57M
| $24K | ﹤0.01% |
12
| – | – |
2018 Q2
7 quarters
|
|
4720
NN Inc
NNBR
$372M
| $24K | ﹤0.01% |
13,767
-231,311
| -94% | -$1.66M |
2013 Q2
27 quarters
|
|
|
EVFM
4721
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $24K | ﹤0.01% |
302
-7
| -2% | -$560 |
2019 Q2
3 quarters
|
|
|
MSON
4722
DELISTED
Misonix Inc
MSON
| $24K | ﹤0.01% |
2,575
-46
| -2% | -$698 |
2019 Q2
3 quarters
|
|
|
SHSP
4723
DELISTED
SharpSpring, Inc.
SHSP
| $24K | ﹤0.01% |
3,951
+598
| +18% | +$6.43K |
2019 Q2
3 quarters
|
|
|
MACK
4724
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $24K | ﹤0.01% |
11,157
+732
| +7% | +$2.14K |
2013 Q2
27 quarters
|
|
4725
Biglari Holdings Class B
BH
$1.16B
| $23K | ﹤0.01% |
439
-18
| -4% | -$1.77K |
2016 Q3
14 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.